Patients With Urologic Cancer Need Psycho-oncologic Support to Manage High Stress

Share this content:
More than half of patients with urologic tumors have high stress and require psycho-oncologic support.
More than half of patients with urologic tumors have high stress and require psycho-oncologic support.

Patients with urologic cancer, particularly prostate cancer, should be offered psycho-oncologic support to manage high stress caused by emotional stressors.1

In a study presented at the 2017 Genitourinary Cancer symposium, researchers from the Department of Urology at the University Hospital Cologne in Cologne, along with researchers from RWTH University Aachen, the Urological Clinic in Aachen, and Cologne University in Cologne, all in Germany, evaluated the psychological distress of patients with urogenital malignancies, particularly patients with testicular cancer and prostate cancer.1

Patient distress was assessed using the distress thermometer, a screening tool developed by the National Comprehensive Cancer Network. The distress thermometer is a 36-item problem checklist that subdivides the causes of distress into 5 main categories: practical, family, emotional, spiritual/religious, or physical. Oncology nurses play an important role in the success of the distress-screening tool because they have the most interaction with the patient.2

The researchers found that the most common form of stressors were of emotional origin, specifically fear (50%), worry (44%), nervousness (42%), sleep disorders (39%), and fatigue (32%). Sixty-four percent of patients with urologic tumors had a high stress level and required psycho-oncologic support. Patients with prostate cancer had higher stress levels than patients with testicular cancer in the subgroups of metastatic disease, secondary therapy, and salvage treatment.

The investigators conclude that more than half of patients with urologic tumors should be offered psycho-oncologic support. In particular, patients with advanced-stage prostate cancer have a high stress level. Therefore, urologic oncology clinicians should be aware of their patients' psychologic distress to identify high-risk patients and provide them with appropriate psycho-oncologic support.

References

1. Paffenholz P, Angerer-Shpilenya M, Salem J, et. al. Distress screening in patients with urogenital malignancies. Poster presented at: 2017 Genitourinary Cancers Symposium; February 16-18, 2017; Orlando, Florida. Abstract 412.

2. Vitek L, Rosenzweig MQ, Stollings S. Distress in patients with cancer: definition, assessment, and suggested interventions. Clin J Oncol Nurs. 2007;11(3):413-418. doi: 10.1188/07.CJON.413-418

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs